Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB Cash ratio

Cash ratio at other companies

Illumina logo
IlluminaILMN
0.7×-0.1×
Revvity logo
RevvityRVTY
0.7×-1.1×
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
3.9×-0.6×
Agilent Technologies logo
Agilent TechnologiesA
0.8×+0.1×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.2×-0.1×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
1×-1.8×

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Calculated from Pacific Biosciences of California’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's cash ratio?
Pacific Biosciences of California (PACB) reported cash ratio of 0.9× in Q1 2026.
How has Pacific Biosciences of California's cash ratio changed year-over-year?
Pacific Biosciences of California's cash ratio decreased by 2.9% year-over-year, from 0.9× to 0.9×.
What is the long-term trend for Pacific Biosciences of California's cash ratio?
Over 5 years (2020 to 2025), Pacific Biosciences of California's cash ratio has grown at a -16.7% compound annual growth rate (CAGR), from 2.2× to 0.9×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.